← Leaderboards
Jeffrey B Warner
University Of Louisville
$92,377
Attributed
$92,377
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $34.8K · FY2020–22$50K$37.5K$25K$12.5K$0
'20
'21
'22
Funding mix
By agency
NIH$92,377 · 1
By mechanism
F31$92,377 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Louisville
Same institution · by research overlap
- Jason L Hellmann$2,697,371
- Craig J McClain$36,863,296
- Irina A. Kirpich$5,792,814
- Roberto Bolli$36,238,342
- John A Auchampach$10,409,762
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectAlcohol ExposureAlcoholic HepatitisAlcoholic Liver DiseasesAlcoholsAnimalsAnti-Inflammatory AgentsAnxa5 GeneAreaAttenuatedBasic ScienceBench To BedsideBiologicalCareerCareer DevelopmentCareer NetworkingCell DeathCell LineCell PhysiologyCellsCellular BiologyCessation Of LifeChronicAblation
Grant awards (3)
sEH Inhibition in Alcoholic Liver Disease: A Novel Therapeutic Strategy$24,783
F31 · FY2022 · AA · contact PI
sEH Inhibition in Alcoholic Liver Disease: A Novel Therapeutic Strategy$32,768
F31 · FY2021 · AA · contact PI
sEH Inhibition in Alcoholic Liver Disease: A Novel Therapeutic Strategy$34,826
F31 · FY2020 · AA · contact PI